Characteristics and outcome of octogenarian versus young patients (pts) with metastatic castrate-resistant prostate cancer (mCRPC) treated with ketoconazole.

被引：0
|
作者：
Sinibaldi, Victoria J.
Dadon-Nachum, Michal
Gottfried, Maya
Maimon, Natalie
Dovrish, Zamir
Peer, Avivit
Neumann, Avivit
Sella, Avishay
Kovel, Svetlana
Carducci, Michael Anthony
Eisenberger, Mario A.
Kejzman, Daniel
机构：
[1] Johns Hopkins, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD USA
[2] Meir Med Ctr, Dept Oncol, Kefar Sava, Israel
[3] Meir Med Ctr, Lung Canc Unit, Kefar Sava, Israel
[4] Tel Aviv Univ, Sackler Sch Med, Meir Med Ctr, Genitourinary Oncol Serv,Div Oncol, Kefar Sava, Israel
[5] Meir Med Ctr, Dept Internal Med D, Kefar Sava, Israel
[6] Rambam Hlth Care Campus, Haifa, Israel
[7] Rambam Med Ctr, Dept Oncol, Haifa, Israel
[8] Assaf Harofeh Med Ctr, IL-70300 Zerifin, Israel
[9] Asaf Harofe Med Ctr, Dept Oncol, Zerifin, Israel
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2014年 / 32卷 / 04期
关键词：
D O I：
10.1200/jco.2014.32.4_suppl.256
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
256
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Characteristics and outcome of octogenarian versus young patients (pis) with metastatic castrate resistant prostate cancer (mCRPC) treated with ketoconazole
    Sinibaldi, Victoria J.
    Dadon-Nachum, Michal
    Gottfried, Maya
    Maimon, Natalie
    Dovrish, Zamir
    Peer, Avivit
    Neumann, Avivit
    Sella, Avishay
    Kovel, Svetlana
    Carducci, Michael Anthony
    Eisonberger, Mario A.
    Keizman, Daniel
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [2] Metastatic Castrate-Resistant Prostate Cancer (mCRPC)
    Karnes, R. Jeffrey
    Ahmed, Mohamed E.
    APPLIED RADIOLOGY, 2021, 50 (01) : 42 - 43
  • [3] Impact of comorbidity on outcome in men with metastatic castrate-resistant prostate cancer (mCRPC)
    Zist, A.
    Amir, E.
    Ocana, A.
    Seruga, B.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S703 - S703
  • [4] Enzalutamide after abiraterone in patients with metastatic castrate-resistant prostate cancer (mCRPC).
    Sandhu, Gurprataap Singh
    Parikh, Rahul Atul
    Appleman, Leonard Joseph
    Friedland, David
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (04)
  • [5] Correlation of increased eosinophil count following sipuleucel-T treatment with outcome in patients (pts) with metastatic castrate-resistant prostate cancer (mCRPC).
    McNeel, Douglas G.
    Lin, Daniel W.
    Gardner, Thomas
    Sheikh, Nadeem A.
    Whitmore, James Boyd
    Sims, Robert Brownell
    Dreicer, Robert
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [6] PSMA heterogeneity analysis in patients with metastatic castrate-resistant prostate cancer (mCRPC): Imaging versus CTCs.
    Morris, Michael J.
    Vogelzang, Nicholas J.
    Sartor, A. Oliver
    Armour, Alison A.
    Messmann, Richard Adam
    Groaning, Michael
    Robarts, Adam
    Tolcher, Anthony W.
    Gordon, Michael S.
    Babiker, Hani M.
    Kuo, Phillip
    Kearney, Megan
    Jendrisak, Adam
    Wang, Yipeng
    Landers, Mark Andrew
    Petrylak, Daniel Peter
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (06)
  • [7] Exosomal microRNA as prognostic biomarkers in metastatic castrate-resistant prostate cancer (mCRPC).
    Kohli, Manish
    Huang, Xiaoyi
    Yuan, Tiezheng
    Sun, Zhifu
    Costello, Brian Addis
    Quevedo, Fernando
    Tan, Winston
    Nandy, Debashis
    Longenbach, Sherri
    Wang, Liang
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (04)
  • [8] Pembrolizumab (pembro) in heavily pretreated metastatic castrate-resistant prostate cancer (mCRPC).
    Moses, Marcus Marie
    Ledet, Elisa
    Manogue, Charlotte
    Lewis, Brian E.
    Barata, Pedro C.
    Sartor, A. Oliver
    Layton, Jodi Lyn
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (07)
  • [9] Treatment outcomes for metastatic castrate-resistant prostate cancer (mCRPC) patients (pts) following docetaxel (D) for hormone sensitive disease
    Schmidt, Andrew Lachlan
    Anton, Angelyn
    Wong, Shirley S.
    Azad, Arun
    Kwan, Edmond Michael
    Spain, Lavinia Anne
    Torres, Javier
    Muthusamy, Arunbalaji
    Parente, Phillip
    Parnis, Francis
    Goh, Jeffrey C.
    Joshua, Anthony M.
    Pook, David William
    Gibbs, Peter
    Tran, Ben
    Weickhardt, Andrew James
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (06)
  • [10] Metastatic castrate-resistant prostate cancer
    Schellhammer, Paul
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2015, 33 (01) : 51 - 52
12345